Skip to main content
Tags: supreme court | journal | abortion | pill | fda | approval | studies

Journal's Abortion Studies Retraction Favors 'Ideology' Over Facts

Packages of the abortion drug Mifepristone displayed at a family planning clinic in Rockville, Maryland. (Getty Images)
 

By    |   Monday, 12 February 2024 07:07 AM EST

Three studies that could play a significant role in the case against the FDA's abortion pill approval that's soon to be before the Supreme Court were removed from an academic journal in a decision that the authors say is "disappointing" and evidence that academic institutions' supposed impartiality is eroding and being driven by "ideology" over "facts."

Next month, the high court is scheduled to hear arguments in a case that involves challenging access to the abortion pill and the FDA's regulatory approval process.

Marisa Herman

Marisa Herman, a Newsmax senior reporter, focuses on major and investigative stories. A University of Florida graduate, she has more than a decade of experience as a reporter for newspapers, magazines, and websites.

© 2024 Newsmax. All rights reserved.


platinum
Three studies that could play a significant role in the case against the FDA's abortion pill approval that's soon to be before the Supreme Court were removed from an academic journal in a decision that the authors say is "disappointing."
supreme court, journal, abortion, pill, fda, approval, studies
936
2024-07-12
Monday, 12 February 2024 07:07 AM
Newsmax Media, Inc.
More Platinum Articles
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved